Valsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-570-30
Published March 27, 2019 · Recall initiated: December 31, 2018
Summary
FDA records drug Class II recall D-1037-2019, published March 27, 2019 and initiated December 31, 2018. Recalling firm: Aurobindo Pharma USA Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot Numbers: 470180008A, exp. date Feb 2020; 470180014A, 470180016A, exp. date Mar 2020; 470180032A, exp. date May 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What to do
Voluntary: Firm initiated · Letter
Get an email if VALSARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Product was distributed to major distribution chains throughout the United States.
- Lot
- Lot Numbers: 470180008A, exp. date Feb 2020; 470180014A, 470180016A, exp. date Mar 2020; 470180032A, exp. date May 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmlodipine and Valsartan Tablets USP 10mg/160mg, 30 count bottles, Manufactured for: Aurobindo Pharma USA,March 27, 2019
- FDALosartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDCMarch 27, 2019
- FDAValsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton,January 23, 2019
- FDAValsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
Questions about this recall
Was Valsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-570-30 recalled?
Yes. FDA published recall D-1037-2019 on March 27, 2019. Reported hazard: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN.